Medicus Pharma Ltd (MDCX) - News Archive

Medicus Pharma Ltd. Secures Continued NASDAQ Listing Amidst Promising Developments in Veterinary Oncology November 2024 - By In a significant boost to its market reputation and investor confidence, Medicus Pharma Ltd. h...

Medicus Pharma Ltd. recently announced that it has received Minor Use Minor Species (MUMS) designation from the U.S. Food and Drug Administration (FDA) for its novel therapeutic, the Doxorubicin-Containing Microneedle A...

Advancements in the Treatment of Nodular Basal Cell Carcinoma: An Overview of Recent Developments by Medicus Pharma Ltd. Nodular basal cell carcinoma (BCC) represents the most common form of skin cancer, primarily affec...